| 1 |
33422061 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity. | 2021 Jan 9 |
1 |
| 2 |
33500617 | Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin. | 2021 |
1 |
| 3 |
18701868 | [Doxil--pegylated liposomal doxorubicin]. | 2008 Aug |
1 |
| 4 |
15717735 | Advantages of liposomal delivery systems for anthracyclines. | 2004 Dec |
2 |
| 5 |
15717736 | Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. | 2004 Dec |
1 |
| 6 |
15717739 | Liposomal anthracycline treatment for ovarian cancer. | 2004 Dec |
2 |
| 7 |
15717742 | Cardiac safety of liposomal anthracyclines. | 2004 Dec |
1 |
| 8 |
15717744 | Pharmacoeconomics of liposomal anthracycline therapy. | 2004 Dec |
2 |
| 9 |
14656277 | The role of anthracyclines in second-line therapy of ovarian cancer. | 2003 Nov-Dec |
1 |